Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-03

FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lotronex (alosetron hydrochloride) by Legacy Pharma USA Inc., approving a supplemental submission to the existing ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTRONEX (alosetron hydrochloride)

Snippet

SUPPL AP for LOTRONEX (ALOSETRON HYDROCHLORIDE)